QUOTE AND NEWS
SeekingAlpha  Sep 9  Comment 
By Trevor Lowenthal: In August, I wrote a bullish article on Ligand (NASDAQ:LGND), with a thesis stating that the company's outlook should improve with increasing royalty payments and new collaborations via its Captisol technology platform. I also...
StreetInsider.com  Aug 27  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Ligand+Pharma+%28LGND%29+Reports+FDA+Approval+of+PromactaRevolade+sNDA/9786314.html for the full story.
SeekingAlpha  Aug 22  Comment 
By Amvona: Ligand Pharmaceuticals (NASDAQ:LGND): Institutional holders wasting no time dumping stock in response to mounting insolvency and bankruptcy risks Ligand's largest shareholder, BVF, Inc., sells 484,524 shares A PDF version of the...
Benzinga  Aug 15  Comment 
Avion Pharmaceuticals, LLC, announces the signing of a commercial license agreement with Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) for the development and commercialization of four Captisol-enabled programs. Under the terms of the...
newratings.com  Aug 15  Comment 
WASHINGTON (dpa-AFX) - BGMedicine Inc. (BGMD) plunged over 22 percent on Thursday after the company reported nearly a 26% drop in its Q2 revenues. The company has two commercial products - Galectin-3 ELISA blood test and CardioSCORE blood...
SeekingAlpha  Aug 14  Comment 
By Trevor Lowenthal: Several weeks ago, I wrote a bullish article on Ligand (NASDAQ:LGND), with a thesis stating that the company's outlook should improve with increasing royalty payments and new collaborations via its Captisol technology...
SeekingAlpha  Aug 14  Comment 
By Amvona: Lemelson Capital short stake built as share price collapses on insolvency and bankruptcy risk Rev. Fr. Emmanuel Lemelson, Founder and President of the Lantern Foundation and Chief Investment Officer of Lemelson Capital Management,...
StreetInsider.com  Aug 14  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Ligand+Pharma+%28LGND%29%2C+Avion+Pharma+Enter+Commercial+Licensing+Arrangement+Covering+Captisol-Enabled+Programs/9752653.html for the full story.
StreetInsider.com  Aug 12  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Marinus+Pharma+%28MRNS%29+Enters+Agreement+for+Use+of+Captisol+%28LGND%29/9743264.html for the full story.
StreetInsider.com  Aug 11  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Ligand+Pharma+%28LGND%29+Announces+%24225M+Convetible+Notes+Offering%3B+Approves+%24200M+Buyback/9741051.html for the full story.





You may also be interested in articles related to Ligand Pharmaceuticals (LGND):
 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki